Skip to content
PubMed This is a summary of 57 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 57 referenced papers

Top Authors

Jens Waschke
LMU Klinikum
Khalaf Kridin
Bar-Ilan University
P. Joly
Inserm
Marina Vivarelli
Bambino Gesù Children's Hospital
Manuela Colucci
Bambino Gesù Children's Hospital
Enno Schmidt
University of Lübeck
Zeinab Mohseni Afshar
Kermanshah University of Medical Sciences
Zeinab Aryanian
Razi Hospital
Soheil Ebrahimpour
Babol University of Medical Sciences

Top Institutions

Ranked by publications Top 10 institutions

References

References (57)
  1. 1

    A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols.

    Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, Dmochowski M

    Archives of medical science : AMS 2015; (11(5)):1021-7 doi:10.5114/aoms.2015.54857.

    PMID: 26528346
  2. 2

    Comparative study of indirect immunofluorescence, enzyme-linked immunosorbent assay, and the Tzanck smear test for the diagnosis of pemphigus.

    Zhou T, Fang S, Li C, Hua H

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2016; (45(10)):786-790 doi:10.1111/jop.12439.

    PMID: 27005471
  3. 3

    Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis.

    Liebman TN, Lieberman MR, Burris K

    Dermatology online journal 2016; (22(3)).

    PMID: 27136623
  4. 4

    Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy.

    Sawamura S, Kajihara I, Makino K, et al.

    The Australasian journal of dermatology 2017; (58(3)):e120-e122 doi:10.1111/ajd.12510.

    PMID: 27270472
  5. 5

    Localized pemphigus foliaceus.

    Walker A, Favreau T

    Cutis 2017; (99(1)):E23-E26.

    PMID: 28207020
  6. 6

    Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.

    Kridin K, Zelber-Sagi S, Bergman R

    Acta dermato-venereologica 2017; (97(9)):1095-1099 doi:10.2340/00015555-2706.

    PMID: 28536732
  7. 7

    Insights into the epidemiological link between biting flies and pemphigus foliaceus in southeastern Brazil.

    Vernal S, Pepinelli M, Casanova C, et al.

    Acta tropica 2017; (176()):455-462 doi:10.1016/j.actatropica.2017.09.015.

    PMID: 28941730
  8. 8

    A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab.

    Saleh MA

    Journal of the American Academy of Dermatology 2018; (79(1)):97-103 doi:10.1016/j.jaad.2018.01.029.

    PMID: 29408700
  9. 9

    Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab.

    Sanz-Bueno J, Gallo E, Caro-Gutiérrez D, et al.

    Dermatology online journal 2017; (23(10)).

    PMID: 29469785
  10. 10

    Psoriasiform Pemphigus Foliaceus in an African American Female: An Important Clinical Manifestation.

    Austin E, Millsop JW, Ely H, et al.

    Journal of drugs in dermatology : JDD 2018; (17(4)):471-473.

    PMID: 29601624
  11. 11

    Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study.

    Serwin AB, Koper M, Flisiak I

    International journal of dermatology 2018; (57(8)):933-937 doi:10.1111/ijd.14078.

    PMID: 29873080
  12. 12

    Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.

    Coyner K, Tater K, Rishniw M

    The Journal of small animal practice 2018; (59(9)):553-559 doi:10.1111/jsap.12869.

    PMID: 29961990
  13. 13

    Fogo selvagem: endemic pemphigus foliaceus.

    Hans-Filho G, Aoki V, Bittner NRH, Bittner GC

    Anais brasileiros de dermatologia 2018; (93(5)):638-650 doi:10.1590/abd1806-4841.20188235.

    PMID: 30156612
  14. 14

    Subtype-specific inherited predisposition to pemphigus in the Chinese population.

    Zhang SY, Zhou XY, Zhou XL, et al.

    The British journal of dermatology 2019; (180(4)):828-835 doi:10.1111/bjd.17191.

    PMID: 30230522
  15. 15

    Enzyme-linked immunosorbent assay as a helpful diagnostic tool for pemphigus erythematosus with equivocal histologic and immunofluorescent findings.

    Desai A, Harris J, Motaparthi K

    Dermatology online journal 2018; (24(8)).

    PMID: 30677852
  16. 16

    Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test.

    Van ATT, Nguyen TV, Huu SN, et al.

    Open access Macedonian journal of medical sciences 2019; (7(2)):195-197 doi:10.3889/oamjms.2019.003.

    PMID: 30745956
  17. 17

    Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses.

    Kneiber D, Kowalski EH, Kridin K, Amber KT

    Dermatologic therapy 2019; (32(3)):e12918 doi:10.1111/dth.12918.

    PMID: 30977210
  18. 18

    Non-endemic erythrodermic pemphigus foliaceus: a case with delayed diagnosis and response to rituximab.

    Patsatsi A, Kyriakou A, Douma S, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2019; (17(5)):537-539 doi:10.1111/ddg.13836.

    PMID: 30994241
  19. 19

    [Possible effect of interleukin-17 blockade in pemphigus foliaceus and neutrophilic diseases].

    Kohlmann J, Simon JC, Kunz M, Treudler R

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(8)):641-644 doi:10.1007/s00105-019-4414-8.

    PMID: 31076811
  20. 20

    Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.

    Walter E, Vielmuth F, Wanuske MT, et al.

    Frontiers in immunology 2019; (10()):1128 doi:10.3389/fimmu.2019.01128.

    PMID: 31178865
  21. 21

    Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.

    Colucci M, Carsetti R, Serafinelli J, et al.

    Frontiers in immunology 2019; (10()):1653 doi:10.3389/fimmu.2019.01653.

    PMID: 31379849
  22. 22

    Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin.

    Oktarina DAM, Sokol E, Kramer D, et al.

    Frontiers in immunology 2019; (10()):2635 doi:10.3389/fimmu.2019.02635.

    PMID: 31781120
  23. 23

    Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.

    Ishii K, Yoshida K, Stanley JR, et al.

    The Journal of investigative dermatology 2020; (140(10)):1919-1926.e7 doi:10.1016/j.jid.2020.02.010.

    PMID: 32142800
  24. 24

    The ISCCA flow protocol for the monitoring of anti-CD20 therapies in autoimmune disorders.

    Gatti A, Buccisano F, Scupoli MT, Brando B

    Cytometry. Part B, Clinical cytometry 2021; (100(2)):194-205 doi:10.1002/cyto.b.21930.

    PMID: 32598578
  25. 25

    Epidemiology and Factors Associated with Remission of Pemphigus Vulgaris and Foliaceus in Singapore.

    Cai SC, Zhao X, Tang MB, Lim YL

    Annals of the Academy of Medicine, Singapore 2020; (49(6)):367-376.

    PMID: 32712634
  26. 26

    Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate.

    Lewis HA, Chen DY, Rosman IS, et al.

    Dermatology online journal 2020; (26(6)).

    PMID: 32815695
  27. 27

    B-cell targeted therapies in pemphigus.

    Maglie R, Antiga E, Payne AS

    Italian journal of dermatology and venereology 2021; (156(2)):161-173 doi:10.23736/S2784-8671.20.06694-8.

    PMID: 33016669
  28. 28

    Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.

    Abida O, Bahloul E, Elloumi N, et al.

    BioMed research international 2020; (2020()):6541761 doi:10.1155/2020/6541761.

    PMID: 33204706
  29. 29

    Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.

    Shah K, Cragg M, Leandro M, Reddy V

    Biologicals : journal of the International Association of Biological Standardization 2021; (69()):1-14 doi:10.1016/j.biologicals.2020.11.002.

    PMID: 33288390
  30. 30

    Rituximab Therapy for Treatment of Pemphigus in Southeast Asians.

    Kanokrungsee S, Anuntrangsee T, Tankunakorn J, et al.

    Drug design, development and therapy 2021; (15()):1677-1690 doi:10.2147/DDDT.S306046.

    PMID: 33911853
  31. 31

    Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus.

    Werth VP, Culton DA, Concha JSS, et al.

    The Journal of investigative dermatology 2021; (141(12)):2858-2865.e4 doi:10.1016/j.jid.2021.04.031.

    PMID: 34126109
  32. 32

    Differentiating Pemphigus Foliaceus From Pemphigus Vulgaris in Clinical Practice.

    Stumpf N, Huang S, Hall LD, Hsu S

    Cureus 2021; (13(9)):e17889 doi:10.7759/cureus.17889.

    PMID: 34548989
  33. 33

    A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus.

    Putra A, Austel M, Banovic F

    Veterinary dermatology 2022; (33(1)):77-e24 doi:10.1111/vde.13028.

    PMID: 34697841
  34. 34

    An unusual presentation of pemphigus foliaceus following COVID-19 vaccination.

    Lua ACY, Ong FLL, Choo KJL, et al.

    The Australasian journal of dermatology 2022; (63(1)):128-130 doi:10.1111/ajd.13755.

    PMID: 34817063
  35. 35

    Invasive breast cancer found in a patient with new-onset pemphigus foliaceus.

    Liu L, Deng J, Cibull T, Pesce CE

    JAAD case reports 2021; (18()):67-70 doi:10.1016/j.jdcr.2021.10.014.

    PMID: 34841027
  36. 36

    New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.

    Mohaghegh F, Hatami P, Refaghat A, et al.

    Clinical case reports 2022; (10(6)):e05910 doi:10.1002/ccr3.5910.

    PMID: 35662780
  37. 37

    Ocrelizumab, an alternative to rituximab in refractory pemphigus vulgaris management.

    de-la-Rosa-Fernández E, Loizate-Sarrionandia I, González-Rodríguez J, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(9)):e1104-e1106 doi:10.1111/jdv.19133.

    PMID: 37102356
  38. 38

    Localized Pemphigus Foliaceus: Diverse Presentations, Treatment, and Review of the Literature.

    Kunadia A, Moschella S, McLemore J, Sami N

    Indian journal of dermatology 2023; (68(1)):123 doi:10.4103/ijd.ijd_324_22.

    PMID: 37151255
  39. 39

    Juvenile Pemphigus Foliaceus in a Patient With Psoriasis Receiving Narrow-Band Ultraviolet-B: Successful Treatment With Rituximab.

    Yousif J, Gottlieb AB, Al-Dehneem R

    Journal of drugs in dermatology : JDD 2023; (22(8)):830-831 doi:10.36849/jdd.7241.

    PMID: 37556511
  40. 40

    The landscape of the immunoglobulin repertoire in endemic pemphigus foliaceus.

    Calonga-Solís V, Olbrich M, Ott F, et al.

    Frontiers in immunology 2023; (14()):1189251 doi:10.3389/fimmu.2023.1189251.

    PMID: 37575223
  41. 41

    Treatment of Pediatric Pemphigus Foliaceus.

    Carver C, Kalesinskas M, Dheden N, Ahmed AR

    Cureus 2023; (15(9)):e45373 doi:10.7759/cureus.45373.

    PMID: 37779684
  42. 42

    Pemphigus Foliaceus after COVID-19 Vaccination: A Report of Two Cases.

    Pham NN, Nguyen TTP, Vu TTP, Nguyen HT

    Case reports in dermatological medicine 2023; (2023()):1218388 doi:10.1155/2023/1218388.

    PMID: 37900286
  43. 43

    Sporadic Pemphigus Foliaceus in a 3-Year-Old Vietnamese Girl: A Case Report and Literature Review.

    Nguyen TTD, Chau TNT, Doan Vo PT, Nguyen HT

    Case reports in dermatological medicine 2024; (2024()):6748340 doi:10.1155/2024/6748340.

    PMID: 38404530
  44. 44

    Eye and lid involvement as an uncommon feature of pemphigus foliaceus in a pediatric patient.

    Garza-Dávila VF, Santana-Gutiérrez A, Zapata-Salazar N, et al.

    Pediatric dermatology 2024; (41(5)):853-856 doi:10.1111/pde.15594.

    PMID: 38459607
  45. 45

    Red crusty plaques in a young man.

    Farsi M, Johnson CM, Segars K, Rhim J

    Dermatology online journal 2023; (29(5)) doi:10.5070/D329562411.

    PMID: 38478647
  46. 46

    Localized facial pemphigus foliaceus presenting in a dermatomal distribution: A case report.

    Couture-Lapointe C, Rousseau-Théberge M

    SAGE open medical case reports 2024; (12()):2050313X241284113 doi:10.1177/2050313X241284113.

    PMID: 39318656
  47. 47

    A Case of Recurrent Pemphigus Foliaceus Following Noncompliance to Medication.

    Ali M, Ahmad MH, Imran A, et al.

    Clinical case reports 2024; (12(11)):e9622 doi:10.1002/ccr3.9622.

    PMID: 39582723
  48. 48

    Risk of Osteoporosis Associated with Glucocorticoid Use in Pemphigus Vulgaris: Insights from a Retrospective Cohort Study.

    Kaya M, Saraç GA, Acar O, et al.

    Dermatology practical & conceptual 2025; (15(2)) doi:10.5826/dpc.1502a5050.

    PMID: 40401897
  49. 49

    Drug-Induced Pemphigus Foliaceus Potentially Triggered by Piperacillin-Tazobactam, Linezolid, and Additional Factors: A Report of a Rare Case.

    Holi A, Rijal S, Rayamajhi S, Regmi N

    Cureus 2025; (17(5)):e85144 doi:10.7759/cureus.85144.

    PMID: 40599502
  50. 50

    Clinicodemographic characteristics of pemphigus foliaceus: retrospective analysis of clinic-based data for 103 patients in a nonendemic location.

    De D, Sharma A, Hanumanthu V, et al.

    Clinical and experimental dermatology 2026; (51(5)):840-845 doi:10.1093/ced/llaf408.

    PMID: 40931562
  51. 51

    Clinical and Immunological Outcomes of Rituximab Therapy in Pemphigus: A Prospective Observational Study.

    Deo KS, Mishra N, Singh Deora M, et al.

    Dermatology (Basel, Switzerland) 2026; (242(2)):145-151 doi:10.1159/000550170.

    PMID: 41442437
  52. 52

    Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab.

    Naidu V, Jain HA, Yalcinkaya A, et al.

    Frontiers in immunology 2025; (16()):1713987 doi:10.3389/fimmu.2025.1713987.

    PMID: 41459496
  53. 53

    Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

    Horváth B, Hiel MAJ, Strandmoe AL, Meijer JM

    American journal of clinical dermatology 2026; (27(2)):317-327 doi:10.1007/s40257-025-01002-1.

    PMID: 41460304
  54. 54

    Pemphigus Foliaceus Mimicking Erythema Annulare Centrifugum: A Case Report.

    Kobayashi T, Iinuma S, Fujita Y

    Cureus 2026; (18(1)):e100813 doi:10.7759/cureus.100813.

    PMID: 41646576
  55. 55

    A diagnostically challenging case of pemphigus foliaceus without histologic evidence of acantholysis.

    Liu JY, Scumpia P, Ni C, et al.

    Dermatology online journal 2026; (32(1)) doi:10.25251/4gj9fp73.

    PMID: 42246332
  56. 56

    Atypical pemphigus foliaceus with pustular lesions: a case series.

    Pangastuti M, Sundani A, Suwarsa O, et al.

    Journal of medical case reports 2026; (20(1)).

    PMID: 42343341
  57. 57

    Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis.

    Kieffer C, Hebert V, Joly P, Tedbirt B

    Dermatology and therapy 2026; doi:10.1007/s13555-026-01811-0.

    PMID: 42390708